Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Director dealings: Breedon's Clive Watson snaps up shares

(Sharecast News) - Breedon revealed on Wednesday that non-executive director Clive Watson had acquired 1,223 ordinary shares in the FTSE 250-listed construction materials company. Watson, who was appointed to the board in September 2019, purchased the shares on Tuesday at an average price of 371.20p each, for a total value of £4,539.78.

As of 1540 BST, Breedon shares were up 0.81% at 378.64p.

Reporting by Iain Gilbert at Sharecast.com

Top Director Buys

Fragrant Prosperity Holdings Limited (di) (FPP) Director name: Gregory,Nicholas Amount purchased: 686,309 @ 0.87p Value: £5,988.05

Breedon Group (BREE) Director name: Watson,Clive Amount purchased: 1,223 @ 371.20p Value: £4,539.78

Top Director Sells

Frontier Developments (FDEV) Director name: Braben ,David John Amount sold: 14,500 @ 380.00p Value: £55,100.00

Share this article

Related Sharecast Articles

Director dealings: Hilton Food director raises stake
(Sharecast News) - Hilton Food Group revealed on Thursday that non-executive director Bindi Foyle had acquired 3,761 ordinary shares in the FTSE 250-listed food packaging business.
Director dealings: Essentra CEO raises stake
(Sharecast News) - Essentra revealed on Wednesday that chief execuitve Scott Fawcett had acquired 17,483 ordinary shares in the FTSE 250-listed hardware manufacturer.
Director dealings: AB Dynamics CEO snaps up shares
(Sharecast News) - AB Dynamics revealed on Tuesday that chief executive Sarah Matthews-DeMers had acquired 2,000 ordinar shares in the AIM-listed automotive testing and development solution supplier.
Director dealings: Bioventix chairman raises stake
(Sharecast News) - Bioventix revealed on Monday that chairman Ian Nicholson had acquired 1,000 ordinary shares in the AIM-listed biotechnology firm.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.